preview

Variable Interest Entities Essay

Good Essays

Date: October 11, 2011
To: Mr. Philip Long
From: Mr. Kunal Patel
Subject: Recommendations
Introduction
Below are my recommendations to Mr. Philip Long, the CFO of DeviceCo, regarding tasks he has assigned me to do. The tasks entail answering the following questions in my analysis of whether LeaseMed is a Variable Interest Entity (VIE) and if DeviceCo should consolidate LeaseMed as a primary beneficiary: (1) Does DeviceCo qualify for the business scope exception, (2) Does LeaseMed have sufficient equity to finance its activities without additional subordinated financial support, and on the basis of that answer, is LeaseMed a VIE, and (3) Is DeviceCo still required to consolidate LeaseMed as its primary beneficiary? …show more content…

I found DeviceCo met one of the requirements to be considered for the business scope exception. According to ACS 810-10-15-17 one of the requirements for Scope Exception states, that if the reporting entity and its related parties provide more than half of the total of the equity, subordinated debt, and other forms of subordinated financial support to the legal entity based on an analysis of the fair values of the interests in the legal entity, then it qualifies for the Business Scope Exception (ASC 810-10-15-17). Clearly, DeviceCo provides more than half of the total equity of LeaseMed, since DeviceCo invested $550,000 out of the $1 million dollar total equity. This accounts to 55 percent. Therefore since DeviceCo qualifies for the business scope exception, this exempts investors from the remaining provisions of the VIE subsections of ASC 810-10.
Rationale - Does LeaseMed have sufficient equity to finance its activities without additional subordinated financial support? It is stated that DeviceCo has put in $550,000 towards LeaseMed’s equity, while Pharmador put in $450,000. This totals $1 million dollars of equity. All $1 million dollars are considered “at-risk”, since these investments in the legal entity (LeaseMed) participate significantly in profits and losses even if those investments do not carry voting rights (ASC 810-10-15-14).
LeaseMed expects losses of more than $1 million dollars. Due to insufficient qualitative

Get Access